Literature DB >> 9443728

Arteriovenous shunting in patients with multiple myeloma and high-output failure.

S Inanir1, R Haznedar, S Atavci, M Unlü.   

Abstract

UNLABELLED: High-output cardiac failure is one of the cardiovascular problems associated with multiple myeloma and frequently seen in patients with extensive bone lesions. The purpose of this study was to search arteriovenous shunting in patients with multiple myeloma and cardiac failure.
METHODS: After the exclusion of other causes of congestive heart failure, 11 patients whose cardiac indices were higher than or equal to 4 liter/min/m2 were selected for the study (7 women, 4 men; mean age 59.64 +/- 8.92 yr). All patients had Stage II-III disease and femoral involvement in radiological examination. Arteriovenous shunting was determined by means of intra-arterial injection technique of 99mTc-macroaggregated albumin (MAA) particles. A quantitative analysis of all scans was performed, and the results were correlated with cardiac index.
RESULTS: Mean cardiac index was 4.33 +/- 0.36 liter/min/m2 in the study group. In all cases, arteriovenous shunting was detected (18.70% +/- 17.29%), and inhomogenous, increased radioactivity accumulation was revealed in the femoral region (lesion-to-background ratio 2.71 +/- 2.08). This zone corresponded to the area of infiltration in a radiograph. A significant correlation was found between shunting values and cardiac indices (r = 0.7899, p = 0.004, Spearman). Although all patients had varying degrees of anemia, we did not find such a relationship between the degree of anemia and cardiac index.
CONCLUSION: Arteriovenous shunting within involved skeleton contributes significantly to the development of high-output cardiac failure in multiple myeloma.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9443728

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  8 in total

1.  A retrospective analysis of 3954 patients in phase 2/3 trials of bortezomib for the treatment of multiple myeloma: towards providing a benchmark for the cardiac safety profile of proteasome inhibition in multiple myeloma.

Authors:  Jacob P Laubach; Javid J Moslehi; Sanjeev A Francis; Jesús F San Miguel; Pieter Sonneveld; Robert Z Orlowski; Philippe Moreau; Laura Rosiñol; Edward A Faber; Peter Voorhees; Maria-Victoria Mateos; Loreta Marquez; Huaibao Feng; Avinash Desai; Helgi van de Velde; Jennifer Elliott; Hongliang Shi; Edward Dow; Nishith Jobanputra; Dixie-Lee Esseltine; Liviu Niculescu; Kenneth C Anderson; Sagar Lonial; Paul G Richardson
Journal:  Br J Haematol       Date:  2017-05-03       Impact factor: 6.998

2.  A Case of Multiple Myeloma Presenting with High-Output Heart Failure That Improved with Anti-angiogenesis Therapy.

Authors:  Bo Eun Park; Dong Heon Yang; Hyeon Jeong Kim; Yoon Jung Park; Hong Nyun Kim; Se Yong Jang; Myung Hwan Bae; Jang Hoon Lee; Hun Sik Park; Yongkeun Cho; Shung Chull Chae
Journal:  Int J Heart Fail       Date:  2020-06-11

3.  Pulmonary hypertension complicating multiple myeloma.

Authors:  Udhay Krishnan; Tomer M Mark; Ruben Niesvizky; Irina Sobol
Journal:  Pulm Circ       Date:  2015-09       Impact factor: 3.017

4.  Integrated safety profile of single-agent carfilzomib: experience from 526 patients enrolled in 4 phase II clinical studies.

Authors:  David Siegel; Thomas Martin; Ajay Nooka; R Donald Harvey; Ravi Vij; Ruben Niesvizky; Ashraf Z Badros; Sundar Jagannath; Leanne McCulloch; Kanya Rajangam; Sagar Lonial
Journal:  Haematologica       Date:  2013-08-09       Impact factor: 9.941

5.  High-output heart failure associated with primary plasma cell leukaemia due to arteriovenous shunting: a case report.

Authors:  Yuta Sudo; Hiroshi Inagaki
Journal:  Eur Heart J Case Rep       Date:  2021-09-07

Review 6.  High Output Heart Failure in Multiple Myeloma: Pathogenetic Considerations.

Authors:  Melania Carlisi; Salvatrice Mancuso; Rosalia Lo Presti; Sergio Siragusa; Gregorio Caimi
Journal:  Cancers (Basel)       Date:  2022-01-26       Impact factor: 6.639

7.  High-output cardiac failure revealing primary plasma cell leukemia.

Authors:  Driss Chaoui; Bruno Gallet; Philippe Genet; Babette Mbungani; Ahmad Al Jijakli; Nina Arakelyan; Louisa Mesbah; Laurent Sutton
Journal:  Case Rep Hematol       Date:  2013-03-04

8.  Multiple myeloma presenting with high-output heart failure and improving with anti-angiogenesis therapy: two case reports and a review of the literature.

Authors:  Jason Robin; Bara Fintel; Olga Pikovskaya; Charles Davidson; Jeffrey Cilley; James Flaherty
Journal:  J Med Case Rep       Date:  2008-07-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.